Comparison of continuation rates for hormonal contraception among adolescents
- PMID: 10326194
- DOI: 10.1016/s1083-3188(00)86633-4
Comparison of continuation rates for hormonal contraception among adolescents
Abstract
Background: Inadequate contraception is common among sexually active female adolescents, resulting in a high incidence of unwanted pregnancy. The authors were interested in comparing continuation rates for the different forms of hormonal contraception in this age group.
Methods: A retrospective chart review. The setting was an urban clinic in a large Midwestern city. Participants were 64% black, 34% white, and the average age was 15.5 years (+/- 1.6 SD), with implant users significantly older than oral contraceptive pill (OCP) users (P < .05). Interventions were self-selection to depo-medroxyprogesterone acetate (Depo-Provera; DMPA), levonorgestrel implants (Norplant), or oral contraceptive pills (OCPs). Previous pregnancy was significantly more prevalent in implant and DMPA users than in OCP users (P < .001). Over 4 years of follow-up, continuation rates were significantly higher for implant users than for the other hormonal groups (P < .001). At 1 year, continuation rates were as follows: 82% implants, 45% DMPA, and 12% OCPs. Combining these rates with those of the subsample who switched without interruption to another hormonal method, "continued protection" rates were much higher after 1 year: 96% implants, 83% DMPA, and 49% OCPs. Calculations of contraceptive "restarts," i.e., hormonal method use in those who discontinued and then restarted after a gap of time, also increased to the prevalence of contraceptive protection.
Conclusion: Continuation rates for levonorgestrel implants were significantly higher than those for DMPA and OCPs, the latter group having the lowest continuation rates. Factoring in switches and restarts to other hormonal methods further boosted the prevalence rates of contraceptive use in the adolescent population.
Similar articles
-
A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.J Pediatr. 1996 Nov;129(5):671-6. doi: 10.1016/s0022-3476(96)70148-8. J Pediatr. 1996. PMID: 8917232
-
Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.J Adolesc Health. 1998 Aug;23(2):81-8. doi: 10.1016/s1054-139x(98)00014-7. J Adolesc Health. 1998. PMID: 9714170
-
A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.Pediatrics. 1994 Nov;94(5):687-94. Pediatrics. 1994. PMID: 7936897
-
Contraception in the adolescent patient.Prim Care. 1995 Mar;22(1):145-59. Prim Care. 1995. PMID: 7777635 Review.
-
Long-acting hormonal contraceptives for women.J Steroid Biochem Mol Biol. 1991;40(4-6):697-704. doi: 10.1016/0960-0760(91)90293-e. J Steroid Biochem Mol Biol. 1991. PMID: 1958567 Review.
Cited by
-
Adolescent and young women's experience with the vaginal ring and oral contraceptive pills.J Pediatr Adolesc Gynecol. 2007 Dec;20(6):345-51. doi: 10.1016/j.jpag.2007.06.001. J Pediatr Adolesc Gynecol. 2007. PMID: 18082856 Free PMC article. Clinical Trial.
-
Efficacy, user acceptability, tolerability, and cycle control of a combined contraceptive vaginal ring: the Indian perspective.J Obstet Gynaecol India. 2013 Oct;63(5):337-41. doi: 10.1007/s13224-013-0391-5. Epub 2013 May 1. J Obstet Gynaecol India. 2013. PMID: 24431671 Free PMC article.
-
Provider counseling to young women seeking family planning services.Perspect Sex Reprod Health. 2014 Dec;46(4):223-31. doi: 10.1363/46e1414. Epub 2014 May 1. Perspect Sex Reprod Health. 2014. PMID: 24786186 Free PMC article.
-
Contraception for adolescents with lupus.Pediatr Rheumatol Online J. 2010 Mar 31;8:10. doi: 10.1186/1546-0096-8-10. Pediatr Rheumatol Online J. 2010. PMID: 20356388 Free PMC article.
-
Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate.Rev Bras Ginecol Obstet. 2025 Mar 17;47:e-rbgo9. doi: 10.61622/rbgo/2025rbgo9. eCollection 2025. Rev Bras Ginecol Obstet. 2025. PMID: 40242009 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous